| Primary |
| Hypertension |
40.0% |
| Product Used For Unknown Indication |
19.6% |
| Essential Hypertension |
8.0% |
| Drug Use For Unknown Indication |
5.4% |
| Atrial Fibrillation |
4.0% |
| Blood Pressure |
3.3% |
| Prostatic Disorder |
2.2% |
| Asthma |
1.8% |
| Constipation |
1.8% |
| Cardiac Disorder |
1.6% |
| Depression |
1.6% |
| Schizophrenia |
1.6% |
| Hepatitis C |
1.3% |
| Pain |
1.3% |
| Prophylaxis |
1.3% |
| Back Pain |
1.1% |
| Blood Pressure Increased |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Angina Pectoris |
0.9% |
| Anticoagulant Therapy |
0.9% |
|
| Orthostatic Hypotension |
10.0% |
| Oedema Peripheral |
8.3% |
| Syncope |
8.3% |
| Bradycardia |
5.8% |
| Cerebrovascular Accident |
5.8% |
| Oedema |
5.8% |
| Temperature Intolerance |
5.8% |
| Headache |
5.0% |
| Paraesthesia |
5.0% |
| Vomiting |
5.0% |
| Hypertension |
4.2% |
| Joint Swelling |
4.2% |
| Anaphylactoid Reaction |
3.3% |
| Dizziness |
3.3% |
| Drug Ineffective |
3.3% |
| Hypersensitivity |
3.3% |
| Hypotension |
3.3% |
| Overdose |
3.3% |
| Pruritus |
3.3% |
| Rash |
3.3% |
|
| Secondary |
| Hypertension |
49.0% |
| Product Used For Unknown Indication |
16.7% |
| Drug Use For Unknown Indication |
9.6% |
| Asthma |
2.5% |
| Blood Pressure |
2.1% |
| Atrial Fibrillation |
1.8% |
| Schizophrenia |
1.7% |
| Hypercholesterolaemia |
1.6% |
| Obesity |
1.6% |
| Coronary Artery Disease |
1.5% |
| Essential Hypertension |
1.5% |
| Hepatitis C |
1.3% |
| Neuralgia |
1.3% |
| Prostatic Disorder |
1.3% |
| Angina Pectoris |
1.2% |
| Lower Respiratory Tract Infection |
1.2% |
| Prophylaxis |
1.2% |
| Anxiety |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
| Blood Cholesterol Increased |
0.9% |
|
| Syncope |
13.1% |
| Dyspnoea |
10.9% |
| Swollen Tongue |
10.3% |
| Cerebrovascular Accident |
6.9% |
| Angioedema |
6.3% |
| Feeling Abnormal |
4.6% |
| Fall |
4.0% |
| Hyperkalaemia |
4.0% |
| Renal Failure Acute |
4.0% |
| Renal Impairment |
4.0% |
| Temperature Intolerance |
4.0% |
| Weight Decreased |
4.0% |
| Hypotension |
3.4% |
| Wrong Drug Administered |
3.4% |
| Dizziness |
2.9% |
| Liver Disorder |
2.9% |
| Orthostatic Hypotension |
2.9% |
| Respiratory Arrest |
2.9% |
| Salivary Hypersecretion |
2.9% |
| Telangiectasia |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.1% |
| Drug Use For Unknown Indication |
20.5% |
| Hypertension |
18.8% |
| Rheumatoid Arthritis |
4.6% |
| Diabetes Mellitus |
3.5% |
| Blood Pressure |
3.2% |
| Pain |
2.6% |
| Depression |
2.4% |
| Type 2 Diabetes Mellitus |
2.3% |
| Blood Cholesterol Increased |
1.9% |
| Prophylaxis |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Osteoporosis |
1.8% |
| Atrial Fibrillation |
1.6% |
| Anxiety |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypercholesterolaemia |
1.0% |
| Hyperlipidaemia |
1.0% |
| Cardiac Disorder |
0.9% |
| Diffuse Large B-cell Lymphoma |
0.9% |
|
| Vomiting |
12.2% |
| Weight Decreased |
8.1% |
| Renal Failure Acute |
7.1% |
| Tremor |
6.1% |
| Nausea |
5.8% |
| Renal Failure |
5.3% |
| Weight Increased |
5.1% |
| Pain |
4.7% |
| Myocardial Infarction |
4.6% |
| Syncope |
4.4% |
| Myalgia |
4.1% |
| Urinary Tract Infection |
4.1% |
| Oedema Peripheral |
4.0% |
| Death |
3.9% |
| Pain In Extremity |
3.9% |
| Pulmonary Embolism |
3.8% |
| Drug Ineffective |
3.3% |
| Visual Impairment |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Somnolence |
3.0% |
|
| Interacting |
| Hypertension |
41.8% |
| Coronary Artery Disease |
10.6% |
| Product Used For Unknown Indication |
10.6% |
| Hyperlipidaemia |
5.3% |
| Type 2 Diabetes Mellitus |
5.3% |
| Prostatic Disorder |
4.7% |
| Hepatitis C |
3.5% |
| Drug Use For Unknown Indication |
2.4% |
| Hypercholesterolaemia |
2.4% |
| Atrial Fibrillation |
1.8% |
| Blood Pressure Abnormal |
1.8% |
| Hiv Wasting Syndrome |
1.8% |
| Localised Infection |
1.8% |
| Blood Cholesterol Increased |
1.2% |
| Gastrointestinal Disorder |
1.2% |
| Hypothyroidism |
1.2% |
| Prophylaxis |
1.2% |
| Anticoagulant Therapy |
0.6% |
| Anxiety |
0.6% |
| Arthritis |
0.6% |
|
| Syncope |
32.1% |
| Drug Interaction |
17.9% |
| Myalgia |
10.7% |
| Atrial Fibrillation |
7.1% |
| Chest Discomfort |
3.6% |
| Dizziness |
3.6% |
| Drug Ineffective |
3.6% |
| Drug Prescribing Error |
3.6% |
| Gallop Rhythm Present |
3.6% |
| Hypotension |
3.6% |
| Renal Impairment |
3.6% |
| Urinary Incontinence |
3.6% |
| Vertigo |
3.6% |
|
